Burroughs Wellcome Co.
Country not established
- Devices
- 17
What Burroughs Wellcome Co. makes
The company produces diagnostic reagents and immunoassay kits for laboratory testing, including cell-based assays (e.g., SAC-CEL, DAC-CEL T4, DAC-CEL HCG), fluorescent antibodies (e.g., Fluorescent Anti-Human C3), and rapid diagnostic tests (e.g., STREP-TEX, CAMMADISK DIGOXIN). It also manufactures vaccines and immunotherapeutic agents (e.g., THYMUNE-M, THYMUNE-T) and serological reagents for detecting antibodies and antigens, such as CRP-WELLCOTEST and WELLCOGEN Group B.
These products are classified under FDA’s Class I and Class II regulatory categories, with most requiring 510(k) clearance. The company’s devices are listed in the FDA’s 510(k) database, and the portfolio operates under US regulatory oversight. No EU or international registries are referenced in the provided data.
Catalogue
Search and filter all 17 devicesFrequently asked questions
How many devices does Burroughs Wellcome Co. have in the registry?
The registry currently lists 17 devices for Burroughs Wellcome Co.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Burroughs Wellcome Co.'s devices?
Among its 17 most recently registered devices, Burroughs Wellcome Co. has devices listed in FDA 510(k) (17 devices).
What risk classes do Burroughs Wellcome Co.'s devices fall under?
Among its 17 most recently registered devices, the classes recorded for Burroughs Wellcome Co.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Burroughs Wellcome Co. in the registry?
The most recently registered devices listed for Burroughs Wellcome Co. include SAC-CEL, THYMUNE-M, TOXHA TEST and DAC-CEL T4.